via Pioneering Minds
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic ...
- Nvidia Looks to Genentech for Its Next Leap in AI Drug Discovery
Nvidia has expanded in artificial intelligence (AI)-based life sciences through a new AI drug discovery collaboration with Roche’s Genentech subsidiary.
- Artificial Intelligence (AI) Diagnosis Market to Reach US$ 5,773.6 Million by 2030: Coherent Market Insights
Artificial intelligence diagnostics involves the use of advanced algorithms and cognitive computing to emulate human diagnostic skills and provide appropriate clinical diagnosis and treatment options.
- Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
Evommune will leverage Accutar's AI-empowered drug discovery platform for therapies targeting chronic inflammatory diseases PALO ALTO, Calif. and ...
- Cradle's AI-powered protein programming platform levels up with $24M in new funding
Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. The company exited stealth a little ...
Go deeper with Google Headlines on:
AI designed drug
[google_news title=”” keyword=”AI designed drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Machine learning in medicine
- Machine learning program provides more accurate understanding of peptide sequences in cells
Machine learning is now helping researchers analyze the makeup of unfamiliar cells, which could lead to more personalized medicine in the treatment of cancer and other serious diseases.
- New machine learning model predicts cardiac arrest in ICU patients using ECG data with high accuracy
Electrocardiogram (ECG) data from a large retrospective cohort to extract various heart rate variability (HRV) measures.
- Understanding Radiomics Features and Machine Learning in Medical Imaging
The integration of radiomics features and machine learning algorithms holds immense potential in several areas of medical imaging. One of the most promising applications is in cancer diagnosis and ...
- Machine Learning in Medicine
6 Yet, this is the promise of machine learning in medicine: the wisdom contained in the decisions made by nearly all clinicians and the outcomes of billions of patients should inform the care of ...
- Machine Learning in Medicine
The purpose of this review is to explore what problems in medicine might benefit from such learning approaches and use examples from the literature to introduce basic concepts in machine learning. It ...
Go deeper with Google Headlines on:
Machine learning in medicine
[google_news title=”” keyword=”machine learning in medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
